156 related articles for article (PubMed ID: 29645079)
1. Anti-nuclear antibodies in patients with breast cancer.
Nisihara R; Machoski MCC; Neppel A; Maestri CA; Messias-Reason I; Skare TL
Clin Exp Immunol; 2018 Aug; 193(2):178-182. PubMed ID: 29645079
[TBL] [Abstract][Full Text] [Related]
2. Circulating auto-antibodies against nuclear and non-nuclear antigens in primary Sjögren's syndrome: prevalence and clinical significance in 335 patients.
Nardi N; Brito-Zerón P; Ramos-Casals M; Aguiló S; Cervera R; Ingelmo M; Font J
Clin Rheumatol; 2006 May; 25(3):341-6. PubMed ID: 16249826
[TBL] [Abstract][Full Text] [Related]
3. [Investigation of antinuclear antibodies in chronic hepatitis B patients].
Şener AG; Aydın N; Ceylan C; Kırdar S
Mikrobiyol Bul; 2018 Oct; 52(4):425-430. PubMed ID: 30522427
[TBL] [Abstract][Full Text] [Related]
4. The relationship between antinuclear antibody data and antibodies against extractable nuclear antigens in a large laboratory cohort.
Craig WY; Ledue TB
Clin Chem Lab Med; 2011 Nov; 50(3):497-502. PubMed ID: 22098438
[TBL] [Abstract][Full Text] [Related]
5. Utility of age, gender, ANA titer and pattern as predictors of anti-ENA and -dsDNA antibodies.
Kang I; Siperstein R; Quan T; Breitenstein ML
Clin Rheumatol; 2004 Dec; 23(6):509-15. PubMed ID: 15801070
[TBL] [Abstract][Full Text] [Related]
6. Dense fine speckled indirect immunofluorescence pattern in an Australian population.
Broadfoot A; Sivertsen T; Baumgart K
Pathology; 2016 Apr; 48(3):247-50. PubMed ID: 27020500
[TBL] [Abstract][Full Text] [Related]
7. Serum antinuclear and extractable nuclear antigen antibody prevalence and associated morbidity and mortality in the general population over 15 years.
Selmi C; Ceribelli A; Generali E; Scirè CA; Alborghetti F; Colloredo G; Porrati L; Achenza MI; De Santis M; Cavaciocchi F; Massarotti M; Isailovic N; Paleari V; Invernizzi P; Matthias T; Zucchi A; Meroni PL
Autoimmun Rev; 2016 Feb; 15(2):162-6. PubMed ID: 26524640
[TBL] [Abstract][Full Text] [Related]
8. Antinuclear antibodies in patients with endometriosis: A cross-sectional study in 94 patients.
Vilas Boas L; Bezerra Sobrinho C; Rahal D; Augusto Capellari C; Skare T; Nisihara R
Hum Immunol; 2022 Jan; 83(1):70-73. PubMed ID: 34686383
[TBL] [Abstract][Full Text] [Related]
9. Determination of Specificity and Pattern of Antinuclear Antibodies (ANA) in Systemic Rheumatic Disease Patients Positive for ANA Testing.
Tipu HN; Bashir MM
J Coll Physicians Surg Pak; 2018 Jan; 28(1):40-43. PubMed ID: 29290190
[TBL] [Abstract][Full Text] [Related]
10. Anti-ENA antibody profiles in patients with hepatitis C virus infection.
Litwin CM; Rourk AR
J Clin Lab Anal; 2018 Mar; 32(3):. PubMed ID: 28605141
[TBL] [Abstract][Full Text] [Related]
11. Detection and identification of antinuclear antibodies (ANA) in a large community hospital.
Verstegen G; Duyck MC; Meeus P; Ravelingien I; De Vlam K
Acta Clin Belg; 2009; 64(4):317-23. PubMed ID: 19810418
[TBL] [Abstract][Full Text] [Related]
12. Detection and identification of significant ANAs in previously determined ANA negative samples.
Kidd K; Cusi K; Mueller R; Goodner M; Boyes B; Hoy E
Clin Lab; 2005; 51(9-10):517-21. PubMed ID: 16285474
[TBL] [Abstract][Full Text] [Related]
13. Circulating antinuclear antibodies in patients with pelvic masses are associated with malignancy and decreased survival.
Heegaard NH; West-Nørager M; Tanassi JT; Houen G; Nedergaard L; Høgdall C; Høgdall E
PLoS One; 2012; 7(2):e30997. PubMed ID: 22363532
[TBL] [Abstract][Full Text] [Related]
14. Prevalence of autoantibodies (ANA, anti ds-DNA, ENA, IMF) and rheumatic syndromes in patients with lymphoproliferative diseases.
Chloraki-Bobota A; Megalakaki C; Repousis P; Chalkiopoulou I; Lalaki I; Trafalis DT; Athanassiou AE; Mitsouli-Mentzikof C
J BUON; 2006; 11(4):485-9. PubMed ID: 17309182
[TBL] [Abstract][Full Text] [Related]
15. Efficiency of different strategies to detect autoantibodies to extractable nuclear antigens.
Almeida González D; Cabrera de León A; Rodríguez Pérez Mdel C; Brito Díaz B; González Hernández A; García García D; Vázquez Moncholi C; Aguirre Jaime A
J Immunol Methods; 2010 Aug; 360(1-2):89-95. PubMed ID: 20600078
[TBL] [Abstract][Full Text] [Related]
16. Autoantibodies in breast cancer sera are not epiphenomena and may participate in carcinogenesis.
Madrid FF; Maroun MC; Olivero OA; Long M; Stark A; Grossman LI; Binder W; Dong J; Burke M; Nathanson SD; Zarbo R; Chitale D; Zeballos-Chávez R; Peebles C
BMC Cancer; 2015 May; 15():407. PubMed ID: 25975273
[TBL] [Abstract][Full Text] [Related]
17. Detection and identification of antinuclear antibodies (ANA) in a large and consecutive cohort of serum samples referred for ANA testing.
Peene I; Meheus L; Veys EM; De Keyser F
Ann Rheum Dis; 2001 Dec; 60(12):1131-6. PubMed ID: 11709455
[TBL] [Abstract][Full Text] [Related]
18. Anti-ENA profiles related with anti-SS-A/Ro. The detection of Ro52 and Ro60 according to the presence of SS-B/La, and ANA pattern and titer.
González DA; Rodríguez CC; Armas LM; Varela AR; Rodríguez IM; Duarte MT; de León AC
Immunol Lett; 2014 Sep; 161(1):6-12. PubMed ID: 24768604
[TBL] [Abstract][Full Text] [Related]
19. Significance of extractable nuclear antigens in childhood autoimmune liver disease.
Gregorio GV; Davies ET; Mieli-Vergani G; Vergani D
Clin Exp Immunol; 1995 Nov; 102(2):308-13. PubMed ID: 7586683
[TBL] [Abstract][Full Text] [Related]
20. Correlation of antinuclear antibody immunofluorescence patterns with immune profile using line immunoassay in the Indian scenario.
Sebastian W; Roy A; Kini U; Mullick S
Indian J Pathol Microbiol; 2010; 53(3):427-32. PubMed ID: 20699497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]